CAS NO: | 11056-06-7 |
生物活性 | Bleomycin is aglycopeptideantibiotic. Bleomycin has potent antitumour activities against a range of lymphomas, head and neck cancers and germ-cell tumours. Bleomycin can be used for the research ofcancerand chemotherapy[1][2][3][4]. | ||||||||
IC50& Target |
| ||||||||
体外研究 (In Vitro) | Bleomycin (0-4 mU/mL; 1 h) induces double-strand break in V79 cells[2].Bleomycin (0-1 mU/mL; 1 h) reduces migration of DNA from S-phase cells[2].Bleomycin (0-3 μg/mL; 1 h) induces chromatid aberrations in G2 cells[3]. | ||||||||
体内研究 (In Vivo) | Bleomycin (1 mg and 10 μg; retro-orbitary sinus injection once) affects cells in mitosis, induces apoptosis in tumor models[4].
| ||||||||
Clinical Trial | |||||||||
CAS 号 | 11056-06-7 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025 |